{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:25:10Z","timestamp":1791476710219,"version":"4.3.4"},"reference-count":170,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/ajg.2017.469","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T08:00:51Z","timestamp":1516089651000},"page":"175-194","source":"Crossref","is-referenced-by-count":728,"title":["ACG Clinical Guideline: Alcoholic Liver Disease"],"prefix":"10.14309","volume":"113","author":[{"given":"Ashwani K","family":"Singal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramon","family":"Bataller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay H","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-9-20210210","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"R3-9-20210210","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1053\/j.gastro.2004.09.020","article-title":"Alcohol and hepatocellular carcinoma.","volume":"127","author":"Morgan","year":"2004","journal-title":"Gastroenterology"},{"key":"R5-9-20210210","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jhep.2016.11.011","article-title":"Histological parameters and alcohol abstinence determine long-term prognosis in patients with alcoholic liver disease.","volume":"66","author":"Lackner","year":"2017","journal-title":"J Hepatol"},{"key":"R6-9-20210210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/hep.29240","article-title":"Main drivers of outcome differ between short and long-term in severe alcoholic hepatitis: a prospective study.","volume":"66","author":"Louvet","year":"2017","journal-title":"Hepatology"},{"key":"R9-9-20210210","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jhep.2016.06.018","article-title":"Heavy daily alcohol intake at the population level predicts the weight of alcohol in cirrhosis burden worldwide.","volume":"65","author":"Stein","year":"2016","journal-title":"J Hepatol"},{"key":"R10-9-20210210","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2015.11.006","article-title":"Alcohol and liver disease in Europesimple measures have the potential to prevent tens of thousands of premature deaths.","volume":"64","author":"Sheron","year":"2016","journal-title":"J Hepatol"},{"key":"R11-9-20210210","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2014.12.005","article-title":"Alcohol drinking pattern and risk of alcoholic liver cirrhosis: a prospective cohort study.","volume":"62","author":"Askgaard","year":"2015","journal-title":"J Hepatol"},{"key":"R13-9-20210210","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets.","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"R14-9-20210210","doi-asserted-by":"crossref","first-page":"e013620","DOI":"10.1136\/bmjopen-2016-013620","article-title":"Disparities between research attention and burden in liver diseases: implications on uneven advances in pharmacological therapies in Europe and the USA.","volume":"7","author":"Ndugga","year":"2017","journal-title":"BMJ Open"},{"key":"R15-9-20210210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJM199001113220205","article-title":"High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism.","volume":"322","author":"Frezza","year":"1990","journal-title":"N Engl J Med"},{"key":"R16-9-20210210","doi-asserted-by":"crossref","first-page":"c1240","DOI":"10.1136\/bmj.c1240","article-title":"Effect of body mass index and alcohol consumption on liver disease: analysis of data from two prospective cohort studies.","volume":"340","author":"Hart","year":"2010","journal-title":"BMJ"},{"key":"R17-9-20210210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.27054","article-title":"Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.","volume":"60","author":"Goh","year":"2014","journal-title":"Hepatology"},{"key":"R18-9-20210210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/j.gastro.2007.10.038","article-title":"Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis.","volume":"134","author":"Nahon","year":"2008","journal-title":"Gastroenterology"},{"key":"R19-9-20210210","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/liv.13007","article-title":"In alcoholic cirrhosis, low-serum hepcidin levels associate with poor long-term survival.","volume":"36","author":"Nahon","year":"2016","journal-title":"Liver Int"},{"key":"R20-9-20210210","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1001\/jama.1996.03530450036029","article-title":"Morbidity and mortality in relation to cigarette smoking in Shanghai, China. A prospective male cohort study.","volume":"275","author":"Yuan","year":"1996","journal-title":"JAMA"},{"key":"R21-9-20210210","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.23500","article-title":"Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study.","volume":"51","author":"Jepsen","year":"2010","journal-title":"Hepatology"},{"key":"R22-9-20210210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-8278(86)80006-X","article-title":"Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage.","volume":"2","author":"Pares","year":"1986","journal-title":"J Hepatol"},{"key":"R23-9-20210210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1530-0277.1981.tb04890.x","article-title":"Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans.","volume":"5","author":"Hrubec","year":"1981","journal-title":"Alcohol Clin Exp Res"},{"key":"R24-9-20210210","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/oxfordjournals.alcalc.a008303","article-title":"Meta-analysis of the effects of alcohol dehydrogenase genotype on alcohol dependence and alcoholic liver disease.","volume":"32","author":"Whitfield","year":"1997","journal-title":"Alcohol Alcohol"},{"key":"R25-9-20210210","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/ajg.2015.137","article-title":"Erwin A et al. pnpla3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease.","volume":"110","author":"Salameh","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"R26-9-20210210","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.cgh.2015.08.018","article-title":"A variant in PNPLA3 associated with fibrosis progression but not hepatocellular carcinoma in patients with hepatitis C virus infection.","volume":"14","author":"Ali","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R27-9-20210210","first-page":"593","article-title":"Ultrastructural alterations in human hepatocytes following ingestion of ethanol with adequate diets.","volume":"49","author":"Lane","year":"1966","journal-title":"Am J Pathol"},{"key":"R28-9-20210210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1056\/NEJM196804182781602","article-title":"Alcohol-induced hepatic injury in nonalcoholic volunteers.","volume":"278","author":"Rubin","year":"1968","journal-title":"N Engl J Med"},{"key":"R29-9-20210210","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.ALC.0000106301.39746.EB","article-title":"Liver disease in heavy drinkers with and without alcohol withdrawal syndrome.","volume":"28","author":"Barrio","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R30-9-20210210","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1097\/MEG.0b013e328355cce0","article-title":"Hepatitis C virus infection in alcoholic hepatitis: prevalence patterns and impact on in-hospital mortality.","volume":"24","author":"Singal","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R31-9-20210210","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.28943","article-title":"Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: a nationwide prospective cohort study.","volume":"65","author":"Askgaard","year":"2017","journal-title":"Hepatology"},{"key":"R32-9-20210210","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/j.1360-0443.1993.tb02093.x","article-title":"Development of the alcohol use disorders identification test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol ConsumptionII.","volume":"88","author":"Saunders","year":"1993","journal-title":"Addiction"},{"key":"R33-9-20210210","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care.","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"R34-9-20210210","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.3748\/wjg.v19.i36.5953","article-title":"Liver transplantation in alcoholic liver disease current status and controversies.","volume":"19","author":"Singal","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R35-9-20210210","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1097\/01.ALC.0000139815.89794.BE","article-title":"A review of genetic, biological, pharmacological, and clinical factors that affect carbohydrate-deficient transferrin levels.","volume":"28","author":"Fleming","year":"2004","journal-title":"Alcohol Clin Exp Res"},{"key":"R36-9-20210210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1530-0277.2010.01170.x","article-title":"Alcohol biomarkers in applied settings: recent advances and future research opportunities.","volume":"34","author":"Litten","year":"2010","journal-title":"Alcohol Clin Exp Res"},{"key":"R37-9-20210210","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.24596","article-title":"Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption.","volume":"54","author":"Staufer","year":"2011","journal-title":"Hepatology"},{"key":"R38-9-20210210","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/liv.12243","article-title":"Rothkirch von G et al. Determination of ethyl glucuronide in hair improves evaluation of long-term alcohol abstention in liver transplant candidates.","volume":"34","author":"Sterneck","year":"2014","journal-title":"Liver Int"},{"key":"R39-9-20210210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the Hospital Anxiety and Depression Scalea review of validation data and clinical results.","volume":"42","author":"Herrmann","year":"1997","journal-title":"J Psychosom Res"},{"key":"R40-9-20210210","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/lt.22259","article-title":"A randomized, controlled study of treatment for alcohol dependence in patients awaiting liver transplantation.","volume":"17","author":"Weinrieb","year":"2011","journal-title":"Liver Transpl"},{"key":"R41-9-20210210","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2014.3628","article-title":"Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.","volume":"311","author":"Jonas","year":"2014","journal-title":"JAMA"},{"key":"R42-9-20210210","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/S0140-6736(07)61814-5","article-title":"Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.","volume":"370","author":"Addolorato","year":"2007","journal-title":"Lancet"},{"key":"R43-9-20210210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.amjmed.2016.10.004","article-title":"Treatment of alcohol use disorder in patients with alcoholic liver disease.","volume":"130","author":"Leggio","year":"2017","journal-title":"Am J Med"},{"key":"R45-9-20210210","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1360-0443.1989.tb00737.x","article-title":"Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).","volume":"84","author":"Sullivan","year":"1989","journal-title":"Br J Addict"},{"key":"R46-9-20210210","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.164.13.1405","article-title":"Management of alcohol withdrawal delirium. An evidence-based practice guideline.","volume":"164","author":"Mayo-Smith","year":"2004","journal-title":"Arch Intern Med"},{"key":"R47-9-20210210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jama.1997.03550020076042","article-title":"Pharmacological management of alcohol withdrawal. A meta-analysis and evidence-based practice guideline. American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal.","volume":"278","author":"Mayo-Smith","year":"1997","journal-title":"JAMA"},{"key":"R50-9-20210210","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"R52-9-20210210","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/hep.22853","article-title":"Management of adult patients with ascites due to cirrhosis: an update.","volume":"49","author":"Runyon","year":"2009","journal-title":"Hepatology"},{"key":"R53-9-20210210","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.jhep.2015.02.033","article-title":"First evidence-based guidelines for the diagnosis and management of hepatic encephalopathy: a welcome development.","volume":"62","author":"Drenth","year":"2015","journal-title":"J Hepatol"},{"key":"R54-9-20210210","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/hep.21907","article-title":"Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.","volume":"46","author":"Garcia-Tsao","year":"2007","journal-title":"Hepatology"},{"key":"R55-9-20210210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4254\/wjh.v3.i5.118","article-title":"Symptoms and signs of acute alcoholic hepatitis.","volume":"3","author":"Basra","year":"2011","journal-title":"World J Hepatol"},{"key":"R56-9-20210210","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hep.27779","article-title":"Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis.","volume":"62","author":"Michelena","year":"2015","journal-title":"Hepatology"},{"key":"R57-9-20210210","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia.","volume":"150","author":"Crabb","year":"2016","journal-title":"Gastroenterology"},{"key":"R58-9-20210210","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis.","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"R59-9-20210210","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1053\/j.gastro.2006.08.020","article-title":"Utility of a new model to diagnose an alcohol basis for steatohepatitis.","volume":"131","author":"Dunn","year":"2006","journal-title":"Gastroenterology"},{"key":"R61-9-20210210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis.","volume":"75","author":"Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"R62-9-20210210","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.cld.2016.02.007","article-title":"Prognosis and prognostic scoring models for alcoholic liver disease and acute alcoholic hepatitis.","volume":"20","author":"Gholam","year":"2016","journal-title":"Clin Liver Dis"},{"key":"R63-9-20210210","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/hep.20503","article-title":"MELD accurately predicts mortality in patients with alcoholic hepatitis.","volume":"41","author":"Dunn","year":"2005","journal-title":"Hepatology"},{"key":"R64-9-20210210","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.","volume":"45","author":"Louvet","year":"2007","journal-title":"Hepatology"},{"key":"R66-9-20210210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0002-9343(84)90776-9","article-title":"Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis.","volume":"76","author":"Mendenhall","year":"1984","journal-title":"Am J Med"},{"key":"R67-9-20210210","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1530-0277.1995.tb01560.x","article-title":"Relationship of protein calorie malnutrition to alcoholic liver disease: a reexamination of data from two Veterans Administration Cooperative Studies.","volume":"19","author":"Mendenhall","year":"1995","journal-title":"Alcohol Clin Exp Res"},{"key":"R68-9-20210210","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cld.2012.08.009","article-title":"Nutrition in alcoholic liver disease.","volume":"16","author":"Singal","year":"2012","journal-title":"Clin Liver Dis"},{"key":"R69-9-20210210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0168-8278(85)80762-5","article-title":"Controlled trial of nutritional supplementation, with and without branched chain amino acid enrichment, in treatment of acute alcoholic hepatitis.","volume":"1","author":"Calvey","year":"1985","journal-title":"J Hepatol"},{"key":"R70-9-20210210","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1177\/0148607185009005590","article-title":"VA Cooperative Study on Alcoholic Hepatitis. III: Changes in protein-calorie malnutrition associated with 30 days of hospitalization with and without enteral nutritional therapy.","volume":"9","author":"Mendenhall","year":"1985","journal-title":"J Parenter Enteral Nutr"},{"key":"R71-9-20210210","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.1840170407","article-title":"A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study.","volume":"17","author":"Mendenhall","year":"1993","journal-title":"Hepatology"},{"key":"R72-9-20210210","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jhep.2010.05.030","article-title":"Enteral nutrition with or without N-acetylcysteine in the treatment of severe acute alcoholic hepatitis: a randomized multicenter controlled trial.","volume":"53","author":"Moreno","year":"2010","journal-title":"J Hepatol"},{"key":"R74-9-20210210","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1023\/A:1018838808396","article-title":"Early feeding or enteral nutrition in patients with cirrhosis after bleeding from esophageal varices? A randomized controlled study.","volume":"42","author":"de Ledinghen","year":"1997","journal-title":"Dig Dis Sci"},{"key":"R77-9-20210210","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/hep.27077","article-title":"Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.","volume":"60","author":"Bajaj","year":"2014","journal-title":"Hepatology"},{"key":"R78-9-20210210","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2015.10.019","article-title":"Management of the critically ill patient with cirrhosis: a multidisciplinary perspective.","volume":"64","author":"Nadim","year":"2016","journal-title":"J Hepatol"},{"key":"R79-9-20210210","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-74-3-311","article-title":"Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy.","volume":"74","author":"Helman","year":"1971","journal-title":"Ann Intern Med"},{"key":"R80-9-20210210","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF01072499","article-title":"Adrenocorticosteroid therapy in alcoholic hepatitis. A prospective, double-blind randomized study.","volume":"22","author":"Blitzer","year":"1977","journal-title":"Am J Dig Dis"},{"key":"R81-9-20210210","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0016-5085(78)90790-4","article-title":"Treatment of alcoholic hepatitis with encephalopathy. Comparison of prednisolone with caloric supplements.","volume":"74","author":"Lesesne","year":"1978","journal-title":"Gastroenterology"},{"key":"R82-9-20210210","first-page":"443","article-title":"A controlled trial of 6-methylprednisolone in acute alcoholic hepatitis. With a note on published results in encephalopathic patients.","volume":"69","author":"Shumaker","year":"1978","journal-title":"Am J Gastroenterol"},{"key":"R83-9-20210210","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/0016-5085(80)90867-7","article-title":"Double-blind controlled trial of prednisolone therapy in patients with severe acute alcoholic hepatitis and spontaneous encephalopathy.","volume":"78","author":"Depew","year":"1980","journal-title":"Gastroenterology"},{"key":"R84-9-20210210","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/gut.23.1.75","article-title":"Controlled trial of methylprednisolone therapy in severe acute alcoholic hepatitis.","volume":"23","author":"Theodossi","year":"1982","journal-title":"Gut"},{"key":"R85-9-20210210","doi-asserted-by":"crossref","first-page":"685","DOI":"10.7326\/0003-4819-110-9-685","article-title":", Herlong HF, Diehl AM et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial.","volume":"110","author":"Carithers","year":"1989","journal-title":"Ann Intern Med"},{"key":"R86-9-20210210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199202203260802","article-title":"A randomized trial of prednisolone in patients with severe alcoholic hepatitis.","volume":"326","author":"Ramond","year":"1992","journal-title":"N Engl J Med"},{"key":"R87-9-20210210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/jhep.2000.8627","article-title":"Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial.","volume":"32","author":"Cabre","year":"2000","journal-title":"Hepatology"},{"key":"R88-9-20210210","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jhep.2005.11.039","article-title":"Antioxidants versus corticosteroids in the treatment of severe alcoholic hepatitisa randomised clinical trial.","volume":"44","author":"Phillips","year":"2006","journal-title":"J Hepatol"},{"key":"R89-9-20210210","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-79-5-625","article-title":", Kirshbaum RJ et al. Prednisone therapy of acute alcoholic hepatitis. Report of a controlled trial.","volume":"79","author":"Campra","year":"1973","journal-title":"Ann Intern Med"},{"key":"R90-9-20210210","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis.","volume":"372","author":"Thursz","year":"2015","journal-title":"N Engl J Med"},{"key":"R91-9-20210210","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM198412063112302","article-title":"Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone.","volume":"311","author":"Mendenhall","year":"1984","journal-title":"N Engl J Med"},{"key":"R92-9-20210210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data.","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"R94-9-20210210","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4292\/wjgpt.v4.i2.16","article-title":"Management practices of hepatitis C virus infected alcoholic hepatitis patients: A survey of physicians.","volume":"4","author":"Singal","year":"2013","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"R95-9-20210210","first-page":"A","article-title":"Evaluation and management of alcoholic hepatitis: A survey of current practices.","volume":"612","author":"Ahn","year":"2009","journal-title":"Hepatology"},{"key":"R97-9-20210210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/j.gastro.2015.05.015","article-title":"Gaps in knowledge and research priorities for alcoholic hepatitis.","volume":"149","author":"Sanyal","year":"2015","journal-title":"Gastroenterology"},{"key":"R98-9-20210210","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1042\/CS20140101","article-title":"The Bioenergetic Health Index: a new concept in mitochondrial translational research.","volume":"127","author":"Chacko","year":"2014","journal-title":"Clin Sci (Lond)"},{"key":"R99-9-20210210","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4254\/wjh.v3.i8.205","article-title":"Corticosteroids and pentoxifylline for the treatment of alcoholic hepatitis: current status.","volume":"3","author":"Singal","year":"2011","journal-title":"World J Hepatol"},{"key":"R100-9-20210210","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/MEG.0b013e328343b085","article-title":"Impact of hepatitis C virus infection on the course and outcome of patients with acute alcoholic hepatitis.","volume":"23","author":"Singal","year":"2011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R101-9-20210210","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/jvh.12399","article-title":"Alcoholic hepatitis and HCV interactions in the modulation of liver disease.","volume":"22","author":"Punzalan","year":"2015","journal-title":"J Viral Hepat"},{"key":"R102-9-20210210","doi-asserted-by":"crossref","first-page":"11929","DOI":"10.3748\/wjg.v20.i34.11929","article-title":"Alcoholic hepatitis and concomitant hepatitis C virus infection.","volume":"20","author":"Shoreibah","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R103-9-20210210","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"R104-9-20210210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1196\/annals.1321.009","article-title":"Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies.","volume":"1024","author":"Franchimont","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R105-9-20210210","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/liv.12939","article-title":"Corticosteroids and occurrence of and mortality from infections in severe alcoholic hepatitis: a meta-analysis of randomized trials.","volume":"36","author":"Hmoud","year":"2015","journal-title":"Liver Int"},{"key":"R107-9-20210210","first-page":"G847","article-title":"Phosphodiesterase inhibitors prevent NSAID enteropathy independently of effects on TNF-alpha release.","volume":"277","author":"Reuter","year":"1999","journal-title":"Am J Physiol"},{"key":"R108-9-20210210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.1840090302","article-title":"Increased tumor necrosis factor production by monocytes in alcoholic hepatitis.","volume":"9","author":"McClain","year":"1989","journal-title":"Hepatology"},{"key":"R109-9-20210210","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"R111-9-20210210","first-page":"96A","article-title":"RB, Draguesku JO et al. Pentoxifylline may prevent renal impairment (hepatorenal syndrome) in severe acute alcoholic hepattis.","volume":"14","author":"McHutchison","year":"1991","journal-title":"Hepatology"},{"key":"R112-9-20210210","first-page":"373A","article-title":"Pentoxifylline reduces disease severity and prevents renal impairment in severe acute acloholic hepatitis: a double-blind placebo-controleld trial.","volume":"44","author":"Sidhu","year":"2006","journal-title":"Hepatology"},{"key":"R113-9-20210210","first-page":"A249","article-title":"Pentoxifylline for treatment of patients with advanced cirrhosis. A randomzied placebo controlled double blind trial.","volume":"46","author":"Leebrec","year":"2007","journal-title":"Hepatology"},{"key":"R115-9-20210210","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3748\/wjg.15.1613","article-title":"Pentoxifylline versus prednisolone for severe alcoholic hepatitis: a randomized controlled trial.","volume":"15","author":"De","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R116-9-20210210","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jhep.2014.05.014","article-title":"Pentoxifylline vs. corticosteroid to treat severe alcoholic hepatitis: a randomised, non-inferiority, open trial.","volume":"61","author":"Park","year":"2014","journal-title":"J Hepatol"},{"key":"R117-9-20210210","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jhep.2007.10.010","article-title":"Early switch to pentoxifylline in patients with severe alcoholic hepatitis is inefficient in non-responders to corticosteroids.","volume":"48","author":"Louvet","year":"2008","journal-title":"J Hepatol"},{"key":"R118-9-20210210","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1007\/s10620-012-2097-4","article-title":"Corticosteroid plus pentoxifylline is not better than corticosteroid alone for improving survival in severe alcoholic hepatitis (COPE trial).","volume":"57","author":"Sidhu","year":"2012","journal-title":"Dig Dis Sci"},{"key":"R119-9-20210210","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial.","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"R120-9-20210210","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1111\/apt.12279","article-title":"Systematic review: pentoxifylline for the treatment of severe alcoholic hepatitis.","volume":"37","author":"Parker","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"R122-9-20210210","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/hep.510260621","article-title":"Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.","volume":"26","author":"Iimuro","year":"1997","journal-title":"Hepatology"},{"key":"R123-9-20210210","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0168-8278(02)00442-7","article-title":"Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.","volume":"38","author":"Tilg","year":"2003","journal-title":"J Hepatol"},{"key":"R124-9-20210210","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2008.10.024","article-title":"Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.","volume":"50","author":"Sharma","year":"2009","journal-title":"J Hepatol"},{"key":"R125-9-20210210","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1572-0241.2004.04034.x","article-title":"A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis.","volume":"99","author":"Menon","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"R126-9-20210210","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/hep.20206","article-title":"A double-blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis.","volume":"39","author":"Naveau","year":"2004","journal-title":"Hepatology"},{"key":"R127-9-20210210","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1053\/j.gastro.2008.08.057","article-title":"A randomized, double-blinded, placebo-controlled multicenter trial of etanercept in the treatment of alcoholic hepatitis.","volume":"135","author":"Boetticher","year":"2008","journal-title":"Gastroenterology"},{"key":"R128-9-20210210","first-page":"G579","article-title":"Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy.","volume":"263","author":"Akerman","year":"1992","journal-title":"Am J Physiol"},{"key":"R129-9-20210210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0891-5849(02)01167-X","article-title":"Oxidative stress in viral and alcoholic hepatitis.","volume":"34","author":"Loguercio","year":"2003","journal-title":"Free Radic Biol Med"},{"key":"R130-9-20210210","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jhep.2007.03.027","article-title":"A randomized trial of antioxidant therapy alone or with corticosteroids in acute alcoholic hepatitis.","volume":"47","author":"Stewart","year":"2007","journal-title":"J Hepatol"},{"key":"R131-9-20210210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0168-8278(03)00476-8","article-title":"A randomized placebo controlled trial of vitamin E for alcoholic hepatitis.","volume":"40","author":"Mezey","year":"2004","journal-title":"J Hepatol"},{"key":"R132-9-20210210","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis.","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"R133-9-20210210","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(94)92025-7","article-title":"Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis.","volume":"343","author":"Fang","year":"1994","journal-title":"Lancet"},{"key":"R134-9-20210210","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.","volume":"64","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"key":"R135-9-20210210","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/hep.1840150115","article-title":"Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: a multicenter sequential trial.","volume":"15","author":"Trinchet","year":"1992","journal-title":"Hepatology"},{"key":"R136-9-20210210","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/hep.1840140625","article-title":"Insulin and glucagon infusion in acute alcoholic hepatitis: a prospective randomized controlled trial.","volume":"14","author":"Bird","year":"1991","journal-title":"Hepatology"},{"key":"R137-9-20210210","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1111\/j.1572-0241.2002.05826.x","article-title":"Anabolic-androgenic steroids for alcoholic liver disease: a Cochrane review.","volume":"97","author":"Rambaldi","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R138-9-20210210","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0016-5085(82)80050-4","article-title":"Propylthiouracil treatment for alcoholic hepatitis: the case of the missing thirty.","volume":"83","author":"Orrego","year":"1982","journal-title":"Gastroenterology"},{"key":"R139-9-20210210","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0016-5085(82)80257-6","article-title":"Double-blind, controlled trial of propylthiouracil in patients with severe acute alcoholic hepatitis.","volume":"82","author":"Halle","year":"1982","journal-title":"Gastroenterology"},{"key":"R140-9-20210210","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.","volume":"109","author":"Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R142-9-20210210","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial.","volume":"57","author":"Banares","year":"2013","journal-title":"Hepatology"},{"key":"R143-9-20210210","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","article-title":"Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study.","volume":"15","author":"Philips","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R144-9-20210210","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/hep.27849","article-title":"Clinical course of acute-on-chronic liver failure syndrome and effects on prognosis.","volume":"62","author":"Gustot","year":"2015","journal-title":"Hepatology"},{"key":"R145-9-20210210","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/TP.0b013e31827afb3a","article-title":"Evolving frequency and outcomes of liver transplantation based on etiology of liver disease.","volume":"95","author":"Singal","year":"2013","journal-title":"Transplantation"},{"key":"R146-9-20210210","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR).","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol"},{"key":"R147-9-20210210","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1600-6143.2009.02869.x","article-title":"Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry).","volume":"10","author":"Burra","year":"2010","journal-title":"Am J Transplant"},{"key":"R148-9-20210210","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/lt.20434","article-title":"Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center.","volume":"11","author":"Julapalli","year":"2005","journal-title":"Liver Transpl"},{"key":"R149-9-20210210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/liv.13030","article-title":"Subjective parameters markedly limit the referral of transplantation candidates to liver transplant centres.","volume":"36","author":"Vidal-Trecan","year":"2016","journal-title":"Liver Int"},{"key":"R150-9-20210210","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","article-title":"Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.","volume":"59","author":"Martin","year":"2014","journal-title":"Hepatology"},{"key":"R151-9-20210210","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.cld.2012.08.013","article-title":"Complications in patients with alcohol-associated liver disease who undergo liver transplantation.","volume":"16","author":"Gaglio","year":"2012","journal-title":"Clin Liver Dis"},{"key":"R152-9-20210210","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.121.5.1638","article-title":"Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology.","volume":"121","author":"Piano","year":"2002","journal-title":"Chest"},{"key":"R153-9-20210210","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jamcollsurg.2010.03.039","article-title":"Sarcopenia and mortality after liver transplantation.","volume":"211","author":"Englesbe","year":"2010","journal-title":"J Am Coll Surg"},{"key":"R154-9-20210210","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/aje\/kwj173","article-title":"The association among smoking, heavy drinking, and chronic kidney disease.","volume":"164","author":"Shankar","year":"2006","journal-title":"Am J Epidemiol"},{"key":"R155-9-20210210","first-page":"6","article-title":"Alcohol use after liver transplantation is independent of liver disease etiology.","volume":"6","author":"Russ","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"R156-9-20210210","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/alcalc\/agl033","article-title":"Liver transplantation for alcoholic liver disease: a systematic review of psychosocial selection criteria.","volume":"41","author":"McCallum","year":"2006","journal-title":"Alcohol Alcohol"},{"key":"R157-9-20210210","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1001\/archinte.167.11.1183","article-title":"A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years.","volume":"167","author":"De Gottardi","year":"2007","journal-title":"Arch Intern Med"},{"key":"R158-9-20210210","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1093\/alcalc\/agv075","article-title":"Feasibility and acceptability of an alcohol addiction therapy integrated in a transplant center for patients awaiting liver transplantation.","volume":"51","author":"Erim","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"R159-9-20210210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/lt.21957","article-title":"Alcohol use while on the liver transplant waiting list: a single-center experience.","volume":"16","author":"Carbonneau","year":"2010","journal-title":"Liver Transpl"},{"key":"R160-9-20210210","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/lt.22370","article-title":"Substance use by liver transplant candidates: an anonymous urinalysis study.","volume":"17","author":"Webzell","year":"2011","journal-title":"Liver Transpl"},{"key":"R161-9-20210210","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/acer.12117","article-title":"Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center.","volume":"37","author":"Addolorato","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"key":"R162-9-20210210","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/TP.0b013e3182375881","article-title":"Neuropsychological functioning in patients with alcohol-related liver disease before and after liver transplantation.","volume":"92","author":"Pegum","year":"2011","journal-title":"Transplantation"},{"key":"R163-9-20210210","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1053\/jlts.2000.19030","article-title":"Quality of life after liver transplantation for alcoholic liver disease.","volume":"6","author":"Pereira","year":"2000","journal-title":"Liver Transpl"},{"key":"R164-9-20210210","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/liv.12553","article-title":"Liver transplantation: a systematic review of long-term quality of life.","volume":"34","author":"Yang","year":"2014","journal-title":"Liver Int"},{"key":"R166-9-20210210","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/lt.21278","article-title":"Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs.","volume":"14","author":"Dew","year":"2008","journal-title":"Liver Transpl"},{"key":"R167-9-20210210","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1600-6143.2010.03232.x","article-title":"Trajectories of alcohol consumption following liver transplantation.","volume":"10","author":"DiMartini","year":"2010","journal-title":"Am J Transplant"},{"key":"R168-9-20210210","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/00007890-200011150-00012","article-title":"Long-term follow-up after liver transplantation for alcoholic liver disease under tacrolimus.","volume":"70","author":"Jain","year":"2000","journal-title":"Transplantation"},{"key":"R169-9-20210210","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jhep.2012.03.014","article-title":"Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication.","volume":"57","author":"Faure","year":"2012","journal-title":"J Hepatol"},{"key":"R170-9-20210210","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/lt.20386","article-title":"Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease.","volume":"11","author":"Cuadrado","year":"2005","journal-title":"Liver Transpl"},{"key":"R171-9-20210210","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/ctr.12427","article-title":"Negative outcomes after liver transplantation in patients with alcoholic liver disease beyond the fifth post-transplant year.","volume":"28","author":"Grat","year":"2014","journal-title":"Clin Transplant"},{"key":"R172-9-20210210","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/lt.21574","article-title":"Failure to fully disclose during pretransplant psychological evaluation in alcoholic liver disease: a driving under the influence corroboration study.","volume":"14","author":"Bajaj","year":"2008","journal-title":"Liver Transpl"},{"key":"R173-9-20210210","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/MCG.0b013e318294148d","article-title":"Outcome after liver transplantation for cirrhosis due to alcohol and hepatitis C: comparison to alcoholic cirrhosis and hepatitis C cirrhosis.","volume":"47","author":"Singal","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R174-9-20210210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/hep.23007","article-title":"Effect of alcoholic liver disease and hepatitis C infection on waiting list and posttransplant mortality and transplant survival benefit.","volume":"50","author":"Lucey","year":"2009","journal-title":"Hepatology"},{"key":"R175-9-20210210","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/lt.21626","article-title":"Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.","volume":"15","author":"Aguilera","year":"2009","journal-title":"Liver Transpl"},{"key":"R176-9-20210210","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1053\/j.gastro.2009.08.070","article-title":"Long-term probability of and mortality from de novo malignancy after liver transplantation.","volume":"137","author":"Watt","year":"2009","journal-title":"Gastroenterology"},{"key":"R177-9-20210210","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/lt.23722","article-title":"Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.","volume":"19","author":"Schrem","year":"2013","journal-title":"Liver Transpl"},{"key":"R178-9-20210210","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/lt.23531","article-title":"Burden of de novo malignancy in the liver transplant recipient.","volume":"18","author":"Chandok","year":"2012","journal-title":"Liver Transpl"},{"key":"R179-9-20210210","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/hed.23943","article-title":"Incidence and long-term survival of patients with de novo head and neck carcinoma after liver transplantation.","volume":"38","author":"Coordes","year":"2016","journal-title":"Head Neck"},{"key":"R180-9-20210210","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/lt.22247","article-title":"Risk factors of lung, head and neck, esophageal, and kidney and urinary tract carcinomas after liver transplantation: the effect of smoking withdrawal.","volume":"17","author":"Herrero","year":"2011","journal-title":"Liver Transpl"},{"key":"R181-9-20210210","doi-asserted-by":"crossref","first-page":"e0155179","DOI":"10.1371\/journal.pone.0155179","article-title":"Spectrum of de novo cancers and predictors in liver transplantation: analysis of the scientific registry of transplant recipients database.","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS ONE (Electronic Resource)"},{"key":"R182-9-20210210","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1111\/ctr.12430","article-title":"Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease.","volume":"28","author":"Thimonier","year":"2014","journal-title":"Clin Transplant"},{"key":"R184-9-20210210","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/lt.24425","article-title":"Severe alcoholic relapse after liver transplantation: What consequences on the graft? A study based on liver biopsies analysis.","volume":"22","author":"Erard-Poinsot","year":"2016","journal-title":"Liver Transpl"},{"key":"R185-9-20210210","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.510230207","article-title":"Incidence of rejection and infection after liver transplantation as a function of the primary disease: possible influence of alcohol and polyclonal immunoglobulins.","volume":"23","author":"Farges","year":"1996","journal-title":"Hepatology"},{"key":"R186-9-20210210","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","article-title":"Early liver transplantation for severe alcoholic hepatitis.","volume":"365","author":"Mathurin","year":"2011","journal-title":"N Engl J Med"},{"key":"R187-9-20210210","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.25544","article-title":"Outcomes after liver transplantation for alcoholic hepatitis are similar to alcoholic cirrhosis: exploratory analysis from the UNOS database.","volume":"55","author":"Singal","year":"2012","journal-title":"Hepatology"},{"key":"R188-9-20210210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/ajt.13586","article-title":"Early liver transplantation for severe alcoholic hepatitis in the United States-a single-center experience.","volume":"16","author":"Im","year":"2016","journal-title":"Am J Transplant"},{"key":"R189-9-20210210","first-page":"8","article-title":"Three-year results of a pilot program in early liver transplantation for severe alcoholic hepatitis.","volume":"8","author":"Lee","year":"2016","journal-title":"Ann Surg"},{"key":"R190-9-20210210","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/lt.24208","article-title":"Liver transplantation for alcoholic hepatitis: a survey of liver transplant centers.","volume":"21","author":"Hasanin","year":"2015","journal-title":"Liver Transpl"},{"key":"R191-9-20210210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jceh.2016.02.001","article-title":"Liver transplantation for alcohol-related liver disease.","volume":"6","author":"Choudhary","year":"2016","journal-title":"J Clin Exp Hepatol"},{"key":"R192-9-20210210","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1111\/ajt.13176","article-title":"Early liver transplantation for patients with acute alcoholic hepatitis: public views and the effects on organ donation.","volume":"15","author":"Stroh","year":"2015","journal-title":"Am J Transplant"},{"key":"R193-9-20210210","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","article-title":"Invasive aspergillosis in patients with severe alcoholic hepatitis.","volume":"60","author":"Gustot","year":"2013","journal-title":"J Hepatol"}],"container-title":["American Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000434-201802000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:18:41Z","timestamp":1786547921000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000434-201802000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":170,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1038\/ajg.2017.469","relation":{},"ISSN":["0002-9270"],"issn-type":[{"value":"0002-9270","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]}}}